The original budget for the Rare Disease Programme of 30 million Euro should be restored, because the current reduction to 6.5 million Euro threatens the success of the programme. Politics Need to Create Rules and Limits Basic biotechnological research will lead to the development of new drugs, vaccinations, diagnostic methods, and medical procedures. In order to derive practical benefits from these achievements for those affected, it is necessary to establish an open dialog and a functioning communication between researchers in biotechnology, other experts, and the general public. Both basic and problem oriented research need to be increasingly funded. There will be no applied research without continuing basic research.
Nations ought to have clear ethical and legal guidelines on research.
A common European standard is necessary. The entire catalogue of demands and tasks drawn up by the workgroups of the European Health Forum has been published as the first Gastein Health Declaration to serve as guide and basis for decisions for European health policy. The paper will be sent to all Directorate Generals of the European Commission concerned, the World Health Organization, the European Parliament, to all European health ministries, European patient organisations, universities, companies, specialised associations, and the media.